|
|
Thursday, July 29, 2004
Agensys Inks Genentech Deal
Santa Monica-based Agensys inked a deal last week to collaborate with biotech firm Genentech to collaborate on research, development, and commercialization of Agensys's proprietary cancer targets. The agreement calls for Genentech to receive exclusive worldwide license to Agensys' patent rights for the therapeutic products. According to the companies, the deal may be worth up to $90M depending on milestone targets. The deal also included an equity investment in Agensys by Genentech.
posted on Thursday, July 29, 2004
|
RSS Feed
Newsletter
Previous news:
Thursday, August 21, 2008
Wednesday, August 20, 2008
Tuesday, August 19, 2008
Monday, August 18, 2008
Friday, August 15, 2008
|